No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs114936301 |
chr7:3224497-3224498 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs73292956 |
chr7:3224500-3224501 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs12700669 |
chr7:3224527-3224528 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs149642789 |
chr7:3224529-3224530 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs73039832 |
chr7:3224543-3224544 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs111347184 |
chr7:3224546-3224547 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs62439464 |
chr7:3224556-3224557 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs555322564 |
chr7:3224558-3224559 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs148375277 |
chr7:3224577-3224578 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs200955949 |
chr7:3224590-3224591 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs112364369 |
chr7:3224591-3224592 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs113298508 |
chr7:3224592-3224593 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs547953801 |
chr7:3224593-3224594 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs182965429 |
chr7:3224600-3224601 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs567662321 |
chr7:3224604-3224605 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs187682785 |
chr7:3224619-3224620 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs6980028 |
chr7:3224631-3224632 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs564888779 |
chr7:3224687-3224688 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs11766275 |
chr7:3224713-3224714 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs538832498 |
chr7:3224721-3224722 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs559082174 |
chr7:3224724-3224725 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs191756170 |
chr7:3224725-3224726 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141535255 |
chr7:3224736-3224737 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs560693912 |
chr7:3224776-3224777 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs4722532 |
chr7:3224801-3224802 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs80281965 |
chr7:3224863-3224864 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs563401630 |
chr7:3224865-3224866 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs532414431 |
chr7:3224893-3224894 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs377540652 |
chr7:3224898-3224899 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs12700670 |
chr7:3224916-3224917 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs375578804 |
chr7:3224917-3224918 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs370543964 |
chr7:3224918-3224919 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs368247828 |
chr7:3224950-3224951 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs370228581 |
chr7:3224965-3224966 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs560129768 |
chr7:3224977-3224978 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs372192359 |
chr7:3224978-3224979 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs11766359 |
chr7:3225023-3225024 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs547866600 |
chr7:3225032-3225033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs183051418 |
chr7:3225033-3225034 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs114778876 |
chr7:3225045-3225046 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs146359272 |
chr7:3225061-3225062 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs569975951 |
chr7:3225067-3225068 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs539301993 |
chr7:3225069-3225070 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs187693479 |
chr7:3225088-3225089 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs111688811 |
chr7:3225098-3225099 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs144018252 |
chr7:3225099-3225100 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs62439465 |
chr7:3225101-3225102 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs574209152 |
chr7:3225117-3225118 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs192411578 |
chr7:3225119-3225120 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs563279237 |
chr7:3225124-3225125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|